Interview with Erik Lommerde, General Manager, Novo Nordisk BV
Coincidentally, our meeting today comes two days after World Diabetes Day. How was this day commemorated in the Netherlands and how does it attest to the acceptance and awareness of…
Address: Oxfordlaan 70, 6229 EV Maastricht, Netherlands
Tel: + 31-43-35 09910
Web: http://www.pharmacell.nl/
PharmaCell provides contract services in the area of human cell & tissue banking & culturing as well as human cell line development and manufacturing of (bio) pharmaceuticals. Next to a GMP license, PharmaCell is the only commercial company in The Netherlands to hold an official license as Registered Tissue Establishment.
PharmaCell is also actively engaged in Research & Development work, both on behalf of some of its customers as well as in research consortia together with Universities, Academic Hospitals and other (bio)tech companies.
PharmaCell is located in the Biopartner Center Maastricht and, therefore, can take advantage of an extensive network to mediate in R&D, financing and housing requirements of clients. Close cooperation with Maastricht University and the associated Academic Hospital gives PharmaCell the unique capability to provide support and/or partnership to R&D companies to bring new products from the lab into the clinic.
PharmaCell offers fully integrated solutions for bio therapeutic proteins and (autologous and allogeneic) cell & tissue therapies, with established competencies which cover the full range of preclinical and clinical services for cell based biopharmaceuticals and therapies, including cell line development, cell banking, cell line characterization, process development and scale-up, custom cGMP manufacturing, lot release, stability testing and final product formulation and fill & finish. PharmaCell offers storage and distribution of Clinical Trail Materials including cell products and tissues and can also coordinate all logistics for autologous cell & tissue therapies throughout the European Union.
Our Maastricht facility was GMP certified in 2006 and in 2007 PharmaCell was granted an official licence as a Registered Tissue Establishment; the only company to hold such a license in The Netherlands.
PharmaCell operates a state-of-the art cGMP facility situated adjacent to the Maastricht University Hospital and within 15 minutes from both the German and Belgian border. Several airports are located close to Maastricht. The facility covers 250 square meters of clean room, classes A, B, C and D. (Classes 100 / 10,000 / 100,000), 180 square meters of R&D and QC laboratories including cryopreservation area.
All our customers have a single point of contact for the management of their project.
Coincidentally, our meeting today comes two days after World Diabetes Day. How was this day commemorated in the Netherlands and how does it attest to the acceptance and awareness of…
Within our reports we typically like to highlight the personalities of the industry and the stories behind the executives that we meet. As you are still relatively new to Ipsen,…
In order to understand the culture behind the business that this association represents, what would you say is the perception of OTC and non-prescriptive drugs in the Netherlands? OTC medicines…
How do you operate in terms of the stakeholder management, with all of your associate members? Do you tend to operate from the committee perspective, or is there an annual…
Having one of the highest penetration rates in Europe, generic medicines play a very important role in the Dutch pharmaceutical market. As this is the principal association for the generics…
While already having worked for Boehringer Ingelheim for quite some time, the end of 2010 marked the completion of your first full year as general manager of this Dutch affiliate.…
Menarini is an extremely proud Italian company in its origins, but also very reliant on international markets. In 2009 approximately 63% of the group’s consolidated revenues came from abroad. What…
When it comes to the pharmaceutical and healthcare industries in the Netherlands, the country has one of the highest generic penetration rates in Europe, it does not have a strong…
WFIA is quite a remarkable organisation that has been, since its inception ten years ago, reporting very good results. The annual results last week showed another strong focus on the…
The Netherlands is famous throughout Europe and the global pharmaceutical community for its research infrastructure – institutes, university hospitals, and public private partnerships. Given this foundation and the size of…
Agendia has experienced remarkable growth in the seven years since you founded the company. In 2009 you expanded the company’s Amsterdam facilities and, in 2010, you doubled the size of…
Founded in 1997 Actelion is certainly the “new kid on the block” when compared to some of the much older mainstays in the pharmaceutical industry. What would you say was…
See our Cookie Privacy Policy Here
